Developer of genomics and bioinformatics platform designed to unify research over democratizing access to omics data. The company's platform offers reproducible and easy-to-share genomics analysis in a single click provides integration with free open-source analysis alongside a marketplace of proprietary alternatives and gives access to visualization of large data sets associated with human genome sequencing, enabling researchers to run complex analyses and generate meaningful insights and secure research over distributed big data.
Developer of a science illustration software designed to empower the world to learn and communicate science through visuals. The company's platform permits scientists to create their compositions without any drawing, export their custom images in their preferred format and showcase their research, enabling scientists to quickly and easily communicate their research.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.